A validative clinical study comparing non-invasive blood glucose measurement by mid-infrared spectroscopy and venous blood glucose in diabetic patients

未提供0 个研究点目标入组 410 人开始时间: 待定最近更新: 2023年12月19日

试验速览

暂无简介。

•Inpatients who meet all of the following selection criteria will be eligible for the study and whose consent has been obtained
•1.Patients who are able to have at least 5 blood samples taken and blood glucose level measured by the test device.
•Age Patients who are at least 18 years old at the time consent is obtained.
•Gender Any gender
•Patients who have been fully informed of the study and who have given written consent of their own free will.
•Patients who possess SMBG equipment (SMBG capable of acquiring data up to 15 times every 10 minutes) or wear CGM equipment (FreestyleLibre) (Measurement B only)

•Patients who meet at least one of the following exclusion criteria will be excluded.
•(1) Patients who require immediate treatment due to changes in blood glucose levels
•(2) Patients who are judged by the principal investigator (subinvestigator) to be inappropriate to participate in this study.

发起方

未提供